Company Filing History:
Years Active: 2020
Title: Innovations of Leo Edwin Deelman
Introduction
Leo Edwin Deelman is a notable inventor based in Peize, Netherlands. He has made significant contributions to the field of medical science, particularly in the area of organ damage treatment. His innovative work focuses on compounds that can restore endothelial function and inhibit reactive oxygen species production.
Latest Patents
Leo Edwin Deelman holds 1 patent for his invention titled "Compound for the prophylaxis or treatment of organ damage." This patent specifically addresses the treatment of diabetic kidney damage through the use of compounds such as 6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)(piperazin-1-yl)methanone and N,6-dihydroxy-2,5,7,8-tetramethylchroman-2-carboxamide. These compounds are designed to restore endothelial function and inhibit the production of reactive oxygen species, thereby providing a therapeutic approach to organ damage.
Career Highlights
Leo is associated with Sulfateq B.V., where he continues to develop and refine his innovative ideas. His work has the potential to significantly impact the treatment of organ damage, particularly in patients suffering from diabetes-related complications.
Collaborations
Leo has collaborated with notable colleagues such as Adrianus Cornelis Van Der Graaf and Robert Henk Henning. These collaborations have likely contributed to the advancement of his research and the successful development of his patented compounds.
Conclusion
Leo Edwin Deelman's contributions to the field of medical science through his innovative patent demonstrate his commitment to improving health outcomes. His work in developing compounds for the treatment of organ damage is a testament to the importance of innovation in healthcare.